jRCT1080223795已完成N/a
TRIBIK Drug Use Surveillance
试验速览
- 阶段
- N/a
- 状态
- 已完成
- 入组人数
- 600
- 试验地点
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 90month old over 至 No limit（—）
- 性别
- All
入选标准
- •Vaccinees who meet both of the following conditions [1] and [2]:
- •[1] Vaccinees who received TRIBIK at the age of 90 months and over.
- •[2] Vaccinees who are able to participate in a questionnaire survey on the health status after vaccination with TRIBIK ( or vaccinees whose guardians are able to participate in the questionnaire survey).
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Special Drug Use Results Surveillance for the use of Odefsey in pregnant womeHIV/AIDSJPRN-UMIN000034028Janssen Pharmaceutical K.K.3
未知
Unknown
Drug use surveillance of Takecab for Supplement to Helicobacter pylori eradicatioThe following diseases in patients for whom H. pylori will be eradicated with triple therapy: Gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, stomach following endoscopic treatment of early gastric cancer, or H. pylori gastritisJPRN-jRCT1080222951TAKEDA PHARMACEUTICAL COMPANY LTD.500
已完成
不适用
Special drug use results surveillance for the use of SIMPONI in ulcerative colitisulcerative colitisJPRN-UMIN000027542Janssen Pharmaceutical K.K.300
招募中
不适用
General Drug Use Surveillance (All Patient Surveillance) of ENSPRYNG Syringes for Subcutaneous Injection - Prevention of relapses of neuromyelitis optica spectrum disorder (including neuromyelitis optica)JPRN-UMIN000041047Chugai Pharmaceutical Co. Ltd.330
招募中
Unknown
Special drug use-results surveillance <Patients with cold agglutinin disease>Cold agglutinin diseaseJPRN-UMIN000049607sanofi K.K.100